AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost...

@TheWallStreetJournal een koppeling hebt gedeeld

2025-03-17 08:50:33 ·

AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio

www.wsj.com

The deal includes the Belgian biotechs vivo cell-therapy platform, which modifies immune cells within the patients body, potentially increasing access to treatment and reducing costs.

0 Reacties ·0 aandelen ·25 Views

Please log in to like, share and comment!

Upgrade to Pro

Choose the Plan That's Right for You

Upgrade